LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Aldeyra Therapeutics (NASDAQ: ALDX)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ALDX Aldeyra Therapeutics
Clark William D / director
04/17/2025
Buy
$2.19
76,760
$168K
76,760
NASDAQ ALDX Aldeyra Therapeutics
PERCEPTIVE ADVISORS LLC / 10 percent owner
04/03/2025
Sell
$1.42
3.40M
$4.828M
5.88M
NASDAQ ALDX Aldeyra Therapeutics
Machatha Stephen / officer: Chief Development Officer
03/04/2025
Buy
$6.17
202,427
$1.249M
202,427